The NeuroSAFE technique significantly improves erectile function outcomes post-prostatectomy, nearly doubling the number of patients with no or mild erectile dysfunction. Intraoperative tissue ...
Hosted on MSN
Trial reveals twice as many men recover erectile function after improved prostate cancer surgery
Professor Greg Shaw, the trial lead from UCL Surgery & Interventional Science and Consultant Urologist at UCLH, said, "Our results show that, by using NeuroSAFE, nearly twice as many men don't have to ...
Read more about the under-prescription of first-line treatments for erectile dysfunction in patients with prostate cancer.
Low-intensity extracorporeal shock wave therapy (LI-SWT) did not improve erectile dysfunction compared to a sham procedure in radical prostatectomy patients. Fewer than 20% of men in the LI-SWT group ...
Results from a phase 3 clinical trial, recently published in The Lancet Oncology, present a significant breakthrough in the field of prostate cancer surgery. The NeuroSAFE technique, a novel approach ...
After prostate cancer treatment, nearly all men suffer temporary or long-term erectile dysfunction. To keep the possibility of recovery alive, some active housekeeping is needed, in the form of penile ...
Prostate cancer is the most common malignancy among men, with over 160,000 new cases diagnosed annually in the United States. Although advances in surgery, radiotherapy, and hormone therapy have ...
Professor Greg Shaw, the trial lead from UCL Surgery & Interventional Science and Consultant Urologist at UCLH, said: “Our results show that, by using NeuroSAFE, nearly twice as many men don’t have to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results